- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
PRISM MEDICO AND PHARMACY LIMITED's 23rd Annual General Meeting saw shareholders adopt the Audited Standalone Financial Statements for the financial year ended March 31, 2025. Key outcomes included the re-appointment of Mrs. Sakshi Laller as a Director. Shareholders also ratified the appointment of M/s. Garg Mendiratta and Associates as Statutory Auditors to fill a casual vacancy caused by a resignation. Additionally, related party transactions were approved. These decisions ensure corporate governance continuity and stakeholder endorsement of the company's financial reporting and operational dealings.